WEILL DAVID sold 22.7% of their position (3.57K shares) of TRANSMEDICS GROUP, INC. on the open market
Open‑market sale worth $524.3K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/6/2026ACC: 0001193125-26-097051
-3.57K
Net shares
Net seller
$524.3K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
3.57K acquired · 7.14K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+3.57K
Price / share
$14.20
Trade value
$50.71K
% of position
29.4%
3/4/2026
12.13K→15.71K
Common Stock
Direct
Shares
−3.57K
Price / share
$146.82
Trade value
$524.29K
% of position
22.7%
3/4/2026
15.71K→12.13K
Total
Net shares
+0.00
Net value
-$473.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/4/2026 | M · Option Exercise | +3.57K | $14.20 | $50.71K | 29.4% | 12.13K | 15.71K |
| Common Stock Direct | 3/4/2026 | S · Sale | −3.57K | $146.82 | $524.29K | 22.7% | 15.71K | 12.13K |
| Total | +0.00 | -$473.59K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
3.57K shares
Shares
−3.57K
Strike price
14.20
Held after
1.43K
Exercisable
—
3/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock3.57K shares | 3/4/2026 | M · Option Exercise | −3.57K | 14.20 | — | 1.43K |